Banoon IVF Center
10
0
0
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 10 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (10)
Humidified Culture and Live Birth After ICSI
Role: collaborator
Comparing HEPES-buffered With Bicarbonate-buffered as Handling Media During the ICSI Procedure on Live Birth Rate
Role: collaborator
Using Cumulase for Denudation of Cycles With ≤ 8 Cumulus-oocytes Complexes
Role: collaborator
Oocyte Vitrification Aided With Cytochalasin B
Role: collaborator
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Cytochalasin B
Role: collaborator
Whether Using Sequential pH Would Improve Human Blastocyst Formation
Role: collaborator
Oocyte Vitrification Aided With Latrunculin A
Role: collaborator
Sequential Versus Single O2 Levels on Human Embryo Development
Role: collaborator
Supplementing Intracytoplasmic Sperm Injection Handling Medium With Chaetoglobosin A ( ICSI-CA)
Role: collaborator
Handling Medium for ICSI With Ionomycin and Latrunculin A
Role: collaborator
All 10 trials loaded